Skip to main content

Supporting policy with scientific evidence

We mobilise people and resources to create, curate, make sense of and use knowledge to inform policymaking across Europe.

Publication | 2024

Congratulations to our colleagues that published excellent papers!

Two scientific articles:

Actinium-225-PSMA radioligand therapy of metastatic castration-resistant prostate cancer (WARMTH Act): a multicentre, retrospective study

Sathekge MM, Lawal IO, Bal C, Bruchertseifer F, Ballal S, Cardaci G, Davis C, Eiber M, Hekimsoy T, Knoesen O, Kratochwil C, Lenzo NP, Mahapane J, Maserumule LC, Mdlophane AH, Mokoala KMG, Ndlovu H, Pant V, Rathke H, Reed J, Sen IB, Singh A, Sood A, Tauber R, Thakral P, Yadav MP, Morgenstern A.

Lancet Oncol. 2024 Jan 10:S1470-2045(23)00638-1. doi: 10.1016/S1470-2045(23)00638-1. Epub ahead of print. PMID: 38218192.


Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

Roberta De Angelis, Elena Demuru, Paolo Baili, Xavier Troussard, Alexander Katalinic, Maria Dolores Chirlaque Lopez, Kaire Innos, Mariano Santaquilani, Marcel Blum, Leonardo Ventura, Keiu Paapsi, Rocco Galasso, Marcela Guevara, Giorgia Randi, Manola Bettio, Laura Botta, Stefano Guzzinati, Luigino Dal Maso, Silvia Rossi, on behalf of the EUROCARE-6 Working Group

Lancet Oncol. 2024 Jan 30: S1470-2045(23)00646-0. doi: Published Online.